WANBURY
Back to Balance Sheet
|
WANBURY Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-5.50 Cr | ₹-5.50 Cr | ₹-5.63 Cr | ₹-5.63 Cr | ₹-3.36 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of WANBURY ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹-5.50 Cr |
Mar2023 | ₹-5.50 Cr |
Mar2022 | ₹-5.63 Cr |
Mar2021 | ₹-5.63 Cr |
Mar2020 | ₹-3.36 Cr |
How is Deferred Tax Assets / Liabilities of WANBURY Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹-5.50 Cr | Negative | |
Mar2023 | ₹-5.50 Cr | Negative | |
Mar2022 | ₹-5.63 Cr | Negative | |
Mar2021 | ₹-5.63 Cr | Negative | |
Mar2020 | ₹-3.36 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of WANBURY
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WANBURY | ₹788.7 Cr | 5.5% | -21.2% | 79.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹428,557.0 Cr | 2.3% | -0.8% | 32.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,994.0 Cr | 3.2% | 1.1% | 51.5% | Stock Analytics | |
CIPLA | ₹116,494.0 Cr | 0.3% | -2% | 10% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,297.0 Cr | -1.8% | 2.7% | 12.7% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,035.0 Cr | 2% | 1.5% | 38% | Stock Analytics |
WANBURY Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WANBURY | 5.5% |
-21.2% |
79.3% |
SENSEX | -1% |
-5% |
5.6% |
You may also like the below Video Courses